B. Dwarakanath

Oncology · 2016–2021

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom B. Dwarakanath trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Karin

Papers from B. Dwarakanath's perspective

Ordered by how strongly the researchers B. Dwarakanath trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hallmarks of cancer: the next generation. (Cell)
  2. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors (Oncogene)
  3. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. (Journal of Clinical Investigation)
  4. Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production (Science)
  5. The basics of epithelial-mesenchymal transition. (Journal of Clinical Investigation)
  6. Immunity, Inflammation, and Cancer (Cell)
  7. Nuclear factor-kappaB in cancer development and progression. (Nature)
  8. The pro- and anti-inflammatory properties of the cytokine interleukin-6. (Biochimica et Biophysica Acta)
  9. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. (Journal of Clinical Investigation)
  10. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. (European Journal of Biochemistry)

Their papers